A group of CDC advisers is weighing some major policy changes to childhood vaccines. The panel is set to meet tomorrow and Friday to discuss whether to scrap the recommendation that newborns should receive hepatitis B vaccinations. >> Now, the vaccine has been credited with significantly preventing the spread of hepatitis B, but skeptics are questioning whether the benefits of the shot actually outweigh the potential health risks.NBC News medical reporter Dr. . Ashal joins us now. Dr. . Dr.. Sel, let's firs ...

Cancer Prevention - New cancer findings are prompting a reevaluation of prevention strategies [1] - Clinicians are rethinking their approach to preventing cancer [1]

New findings about cancer are forcing clinicians to rethink their approach to preventing the disease https://t.co/KTZp1IxqH1 ...

Public Health & Safety - Ticks are flourishing in many parts of the U S [1] - The report provides information on what actions individuals can take regarding ticks [1]

Core Insights - The Polish Presidency of the EU Council emphasizes health policy as a central element of Europe's strategic agenda, focusing on healthcare resilience and digital transformation [1] - Sanofi advocates for a shift from reactive treatment to proactive prevention strategies, highlighting the economic benefits of investing in prevention [2] - The importance of innovation in healthcare systems is underscored, with a call to close the innovation gap and adopt advanced technologies for Europe's long-term prosperity [3][4] Group 1: Prevention and Economic Impact - Sanofi's investment in prevention yields significant returns, with every €1 invested bringing €14 back, and up to €19 for adult immunization [2] - Real-world evidence shows an 80% reduction in winter hospitalizations among infants due to RSV immunization, emphasizing the effectiveness of prevention [2] - Chronic respiratory diseases are a major public health concern in Europe, affecting over 36 million people and accounting for 6% of healthcare expenditure [2] Group 2: Innovation and Competitiveness - The need for Europe to rebuild its leadership in pharmaceutical innovation is critical, as global R&D investments are shifting away [4] - Collaboration between industry and academia, support for emerging biotechnologies, and a conducive regulatory environment are essential for fostering innovation [4] - Digital health and data-driven research are highlighted as transformative elements for strengthening healthcare systems and economic future [3] Group 3: Human Dimension of Innovation - Scientific progress must translate into improved lives for individuals and communities, with a focus on immunization as a key tool [5][6] - The mission is to transition healthcare from treatment to prevention, with immunization saving 154 million lives globally over the past 50 years [6] - Prevention and immunization should be viewed as economic stabilizers, emphasizing the need for a model built on innovation and long-term strength [7]